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ABSTRACT
Osteoarthritis (OA) is an increasingly common deteriorating disorder of the temporomandibular joint (TMJ) for
which there is an urgent need to improve the prevention and cure. Objectives: We aimed to compare low-level
laser (LLL) against corticosteroids as an alternative treatment for TMJ-OA. Methods: Sixty rats with TMJ-OA
were divided into OA (untreated), corticosteroid-treated, and LLL-treated groups. Animals were sacrificed at 1
and 4 weeks after treatment, and their TMJs were dissected for evaluation by histological analysis, histochemical
analysis, and quantitative real-time polymerase chain reaction. Statistical comparison was conducted using oneway analysis of variance. Results: Histopathological examination revealed degenerative changes and loss of
normal architecture in the untreated OA group and that these changes were decreased in both treatment groups. In
histochemical analysis, collagen formation was higher in both treated groups than in the untreated group. Finally,
tumor necrosis factor-α level was the highest in the OA group, followed by the corticosteroid- and LLL-treated
groups. Conclusion: LLL may improve joint OA in the TMJ to a similar extent to corticosteroids and appears to
have superior anti-inflammatory effects in the short-term.
Key words: dexamethasone, low-level laser therapy, osteoarthritis, temporomandibular joint, tumor necrosis
factor-alpha
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INTRODUCTION
Osteoarthritis (OA) is a deteriorating joint disease
characterized by progressive articular cartilage
loss, osteophyte formation, synovial inflammation,
and subchondral bone changes, including increased
thickness that alter the shape and volume. Despite
the common perception, it is not simply a disease of
increased wear and tear but is a disorder of abnormal
remodeling and joint failure.1
Corticosteroids (CS) are potent anti-inflammatory
medications, and intra-articular (IA) injections have
widely been used to treat the symptoms of OA since
approximately 5 decades. However, there have been
alarming reports of post-injection complications,
including the inhibition of proteoglycans synthesis,
cartilage disintegration, and bone necrosis, that have
precluded their use for temporomandibular joint (TMJ)

pain. In addition, high doses of corticosteroids increase
the possibility of aseptic bone necrosis.2 More recently,
a credible non-invasive treatment for TMJ disorders has
been developed. This is low-level laser (LLL) therapy,
which is a conservative and supportive physical therapy
that has anti-inflammatory effects and can treat OA of
the TMJ (i.e., TMJ-OA).3
To date, assessment of the anti-inflammatory effects of
LLL therapy in clinical studies has only been subjective
and based on the induction of pain rather than on the
objective evaluation of inflammation.4 Consequently,
there is a need for more objective and controlled
studies to determine the effects of LLL therapy on
inflammation in TMJ structures.
In this st udy, we compared the possible antiinflammatory effects of LLL therapy with those of
corticosteroids in albino rats with induced TMJ-OA.
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Table 1: Experimental groups
Group І (OA group, untreated) Group ІІ (CS group, treated)

Group ІІІ (LLL group, treated)

Number of rats

20

20

20

OA induction

IA injection of 2 mg of monoiodoacetate

IA injection of 2 mg of monoiodoacetate

IA injection of 2 mg of monoiodoacetate

Treatment

No treatment

IA injection of dexamethasone

LLL therapy

Date of sacrifice

1 and 4 weeks after OA
confirmation

1 and 4 weeks after
dexamethasone administration

1 and 4 weeks after LLLT

Abbreviations: CS, corticosteroids; IA, intra-articular; LLL, low-level laser; OA, osteoarthritis

Table 2. Parameters of the laser device
Characteristics
Laser type
Brand
Model number
Wave length
Operation mode
Power output
Spot size
Energy
Irradiation time

Details
InGaAsP diode laser
Biolase
Epic 10
940 nm
Continuous wave
0.2 W
300 μm
4J
20 s

METHODS
All experiments were conducted in the animal house
at the Faculty of Medicine, Cairo University, Egypt,
after receiving approval from the Ethics Committee
on animal experimentation of the Faculty of Dentistry
(Approval no.16/9/15).
Animals
Sixty adult healthy female albino rats, approximately
3–6 months old and weighing approximately 180–200 g
were used. The animals were housed in a sterile
controlled environment (temperature 23°C ± 5°C with
a 12 h dark/light cycles) and fed with a standard pellet
diet and allowed tap water ad libitum. They were
individually kept in stainless steel cages and then
randomly distributed into three groups of 20 animals
each, as detailed in Table 1.
OA induction and confirmation
A single 2 mg/kg IA injection of monosodium
iodoacetate (provided by Sigma-Aldrich Chemical Co.
St. Louis, MO 63103 USA) dissolved in sterile 0.9%
saline was injected into the right TMJ of rats.5 After 7
days, blood samples were collected from all animals for
biochemical estimation of C-reactive protein.6
Therapeutic interventions
Seven days after induction of OA, animals in Group
ІІ were sedated and given a single IA injection of

1.2 mg/kg dexamethasone (provided by AMRIYA
for pharmaceutical industries, Alexandria, Egypt).7
An Indium Gallium Arsenide Phosphide (InGaAsP)
system model Epic™ Biolase (USA) was used for
the LLL therapy. Rats in Group ІІІ received mild
chloroform sedation, and the tissue over TMJ region
5–10 mm posterior to the lateral eye canthus was
irradiated. Seven 60 s sessions of LLL therapy were
performed every other day for 2 weeks in accordance
with the research by Khozeimeh et al.,8. The selected
physical parameters are summarized in Table 2. .
Animal sacrifice
Animals were sacrificed by intra-peritoneal injection
of 500 mg/kg sodium phenobarbital, as previously
described by Al-Saffar et al.,9 and the TMJ was then
dissected. Tissues were preserved in 10% neutral
buffered formalin for 24 h, dehydrated in ascending
grades of ethyl alcohol, immersed in xylene, and
embedded in paraffin wax. The sections measured 3–4 μm
in thickness.
Histological, histochemical, and polymerase chain
reaction analyses
Routine histological examination was performed by
light microscopy after sections were stained with
hematoxylin and eosin. Next, for histochemical
analysis, sections stained with Masson trichrome were
examined using a Leica Quin 500 analyzer computer
system. Staining was measured as the area and the
area percent stained in a standard measuring frame
in ten fields per group under magnified (×400) light
microscopy transferred to a screen. Areas showing
green color staining were chosen for evaluation.
These areas were masked by a blue binary color to
be measured by the computer system. The means and
standard deviations were obtained for each specimen.
The mRNA expression level of tumor necrosis factoralpha (TNF-α) was quantified by real-time quantitative
PCR (qRT-PCR). We used 1000 ng of the total RNA
from each sample for cDNA synthesis by reverse
transcription with a high-capacity cDNA reverse
transcriptase kit (Applied Biosystem, USA). The cDNA
was subsequently amplified with the Syber Green I
136
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Table 3. Primers sequences for each gene
Target gene
TNF-α
GAPDH

Primer sequence: 5′–3′
Forward: AACTCGAGTGACAAGCCCGTAG
Reverse: GTACCACCAGTTGGTTGTCTTTGA
Forward: CACCCTGTTGCTGTAGCCATATTC
Reverse: GACATCAAGAAGGTGGTGAAGCAG

PCR Master Kit (Fermentas) in a 48-well plate using
a Step One instrument (Applied Biosystem, USA), as
follows: 10 min at 95°C for enzyme activation followed
by 40 cycles of 15 s at 95°C, 20 s at 55°C, and 30 s
at 72°C for the amplification step. Changes in the
expression of each target gene were normalized relative
to the mean critical threshold values of the GAPDH
housekeeping gene by the ΔΔCt method. We used 1
μM of primers specific for each target gene. Primers
sequences are shown in Table 3.
Statistical analysis
Data are presented as means and standard deviations
(SD). Given that analysis using the Kolmogorov–
Smirnov test for normality indicated that most data
were normally distributed, one-way analysis of
variance (ANOVA) was used for comparisons between
groups. This was followed by Tukey’s post-hoc test
when the difference was found to be significant.
Unpaired t-tests were used to compare the same
treatment group between the two observation dates.
The significance level was set at p < 0.05. Statistical
analysis was performed using SPSS 16.0 for Windows
(SPSS, Inc., Chicago, IL, USA).

Gene bank accession number
XM008772775.1
XR598347.1

Figure 1. Sagittal section in condyle (1 week)
A: The OA group shows focal loss of chondrocytes (asterisks)
and widened marrow cavities filled with fibroblast-like cells
(m). B: The CS group shows areas of hyalinization (asterisks),
marrow cavities filled with few chronic inflammatory cells
(m), osteogenic cells (arrow heads), highly mineralized
bone matrix (arrows), vertical and horizontal cracks (c) and
ankylosed disc (dotted arrow). Inset: anterior condyle with
osteoclasts and many reversal lines (arrows) C: The LLL
group shows areas of hyalinization (asterisk), normal marrow
cavities containing few chronic inflammatory cells (m), a
tide mark (arrow heads), newly formed bone matrix (arrows)
and different degrees of mineralization (circle). Also shown:
fibrous layer (F), proliferative layer (P), hypertrophic layer
(H), subchondral bone (SB), and disc (D). (hematoxylin and
eosin, ×400.)

RESULTS
Histological results at 1 week
Histopathological examination of the OA group showed
mild degenerative changes in the condyle (Figure
1A). In the LLL group, similar to that of CS group,
the condyle appeared more or less normal but retained
some degenerative changes. However, in the CS group,
the central region of the disc was ankylosed to the
condyle. At the anterior region along the ligaments’
insertion, osteoclasts were observed in the Howship
lacunae (Figures 1B and 1C). As for the synovial
membrane, there were mild signs of inflammation in
the OA group (Figure 2A), but this appeared normal in
the CS and LLL groups. Large amounts of extravasated,
ruptured, and congested blood vessels were noticed in
the LLL group (Figures 2B and 2C).
Histological results at 4 weeks
Histopathological examination of the OA group showed
moderate degenerative changes in the condyle at 4
weeks (Figure 3A). In the CS and LLL groups, most
of the inf lammatory signs had subsided, but with
some evidence of degeneration persisted (Figures 3B

Figure 2. Photomicrograph of the synovial membrane (1
week)
A: The OA group shows few microvilli (arrow heads)
projecting into the upper joint cavity and numerous
mononuclear cell infiltrates (arrows). B: The CS group has
many villi (arrow heads) protruding into the upper joint
space with few mononuclear cell infiltrates (arrows). C: The
LLL group shows few mononuclear cell infiltrates (arrow)
and extravasated and ruptured blood vessels (RBCs) Also
shown: synovial lining (L) and synovial sub-lining layer
(SL). (hematoxylin and eosin, ×400.)

and 3C). The synovial membrane appeared thickened
and inflamed in the OA group and there was fatty
degeneration in the sub-lining layer (Figure 4A).
This appeared normal in the treated groups, with few
mononuclear cell infiltrates (Figures 4B and 4C).
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Table 4: Masson trichrome mean area percent and TNF-α
relative quantitation at 1 and 4 weeks (ANOVA)
Masson
TNF-α
trichrome
(Mean ± SD)
Groups
(Mean ± SD)
OA1
*8.63c ± 2.32
***3.49f ± 0.27

Figure 3. Sagittal section in condyle (4 weeks)
A: The OA group shows abnormal thickness (asterisk),
calcified cartilage (cc), osteoclasts (OCL), many reversal
lines (arrows), and sclerosis (circle). B: The CS group
shows roughness (arrows), calcified cartilage (cc), atrophied
chondrocytes (asterisks), and marrow cavities filled with
chronic inflammatory cells (m). C: The LLL group shows
calcified cartilage (cc), sclerosis (asterisks), and many reversal
lines (arrows). Also shown: fibrous layer (F), proliferative
layer (P), hypertrophic layer (H), subchondral bone (SB), and
disc (D). (hematoxylin and eosin, ×400.)

CS1

*22.02b ± 2.53

***2.63g ± 0.07

LLL1

*27.85a ± 3.42

***1.90h ± 0.34

OA4

e

**4.62 ± 2.02

****4.61i ± 0.35

CS4

**9.60 d ± 0.57

****2.27j ± 0.43

LLL4

**6.38 ± 2.94

****1.52k ± 0.36

d

Primary comparison was by ANOVA. Significance level
p < 0.05, asterisks indicate that the differences between
compared groups at 1 week (OA1, CS1, LLL1) and 4 weeks
(OA4, CS4, LLL4) were significant. Tukey’s post-hoc test:
means of comparing groups at 1 and 4 weeks with different
superscript letters are significantly different

all groups was statistically significant (P < 0.0001), and
Tukey’s post-hoc test revealed a significant difference
between each compared pair (Table 4).

DISCUSSION

Figure 4. Photomicrograph of the synovial membrane
(4 weeks)
A: The OA group shows thickened synovial lining (L) with
few cellular contents in the sub-lining (SL) layer and fatty
degeneration (asterisks). B: The CS group has many villi
projecting into the upper joint cavity (arrow heads) and few
mononuclear cells (arrows) C: Normal L and SL layers are
shown. (hematoxylin and eosin, ×400.)

Histochemical results (Masson trichrome stain) at
1 and 4 weeks
The highest mean values for the Masson trichrome stain
at 1 week were recorded in the LLL group, followed
by the CS group, and then the OA group. ANOVA
revealed that the difference between all groups was
statistically significant (P < 0.0001), with Tukey’s posthoc test indicating significant differences between each
compared pair (Table 4). The highest mean results for
the Masson trichrome stain at 4 weeks were recorded
in the CS group, followed by LLL group, and then
the OA group. ANOVA revealed that the difference
was statistically significant between all groups (P =
0.008), but Tukey’s post-hoc test revealed no significant
difference between the CS and LLL groups (Table 4).
Polymerase chain reaction for tumor necrosis
factor-alpha at 1 and 4 weeks
The highest mean values were recorded in the OA
group, followed by the CS group, and then the LLL
group. ANOVA revealed that the difference between

Our histological results in the OA group at 1 and 4
weeks revealed a general destruction of the condylar
cartilage and subchondral bone. This resembled the
clinical and experimental observations of Wang et
al., who reported that the condyle was active and
underwent severe destruction and remodeling.5
We also found thickening and roughness of the
fibrous layer with atrophy of the proliferative layer,
consistent with previous findings of chondrocyte
hypertrophy-like changes in OA.10 The hypertrophic
layer also showed focal chondrocyte loss with some
areas of hyalinization. Similarly, in rats injected
with collagenase, it was reported that large areas of
chondrocytes in the superficial and middle zones of
the cartilage disappeared by weeks 1 and 6 because
of cartilage disintegration in the deep and calcified
zones.11 The hypertrophic layer also showed areas of
calcified cartilage in our study. Goldring and Marcu
also showed that naturally resting chondrocytes in OA
were activated and underwent a phenotypic alteration,
resulting in chondrocyte proliferation, which was
followed by raised catabolic activity and hypertrophylike maturation and calcification of the cartilage.12
The subchondral bone showed vertical and horizontal
cracks with widened marrow cavities filled with
chronic inflammatory cells and fibroblast-like cells.
Goldring also reported increases in microcracks,
vascular communication channels, and fissures in
joints with OA. Moreover, they demonstrated that
vascular invasion of bone marrow tissue into the
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subchondral bone induced the synthesis of matrix
metalloproteinases (MMPs) that caused disintegration
of the adjacent cartilage.13 The subchondral bone in
our OA group also showed areas of sclerosis with
large numbers of osteoclasts. Other researchers also
reported that early OA was associated with an increase
in bone resorption,14,15 concluding that subchondral
bone sclerosis and increased adjacent bone volume
were possible adaptive responses.
Similar to previous findings, we observed a tide mark.12
Goldring and Marcu described this as a basophilic line
in histological sections. They concluded that it reflected
an accumulation of macromolecular debris, including
DNA that did not penetrate the barrier between noncalcified and calcified regions. As for the synovial
membrane, it has been reported that the synovial fluid
obtained from patients with OA can enhance bone
resorption by activating the OPG/RANK/RANKL
system. Both OPG and RANKL are synthesized by
chondrocytes and contribute to bone remodeling by
enhancing the maturation and activation of synovial
osteoclasts.16 The changes we observed in the synovium
are consistent with these.
In our study, dexamethasone was used as the gold
standard anti-inflammatory treatment for OA. Although
we gave the rats a single injection, the condylar head
showed many osteoclasts, which indicated resorption.
El-Hakim et al. also observed that IA injection of
dexamethasone into the condylar heads of rats resulted
in massive degradation of the articular fibrocartilage
cap.7 In this study, the ankylosis observed at the disc
in the CS group may have been caused by repeated
IA injections (this group received injections of
monosodium iodoacetate and dexamethasone). Similar
findings were seen on MRIs, with anterior disc
dislocation and severe condylar necrosis after a second
IA injection of triamcinolone.17
We compa re d LLL t he r apy w it h t r a d it ion al
corticosteroid therapy by IA injection. The laser was
applied to three points (capsule, retrodiscal area,
and condylar neck), using the physical parameters
Khozeimeh et al. had previously applied.8 Graciele et
al. also selected multiple points to irradiate a wider joint
area.18 It was notable that most signs of inflammation
subsided after LLL and therapy, which is consistent
with the findings of Peimani and Sardary. They showed
that LLL therapy resulted in marked improvements
in the grade of cartilage defects and the number of
inflammatory cells in rats with induced TMJ-OA.19
Similarly, Barbosa et al. demonstrated that LLL therapy
had a positive effect on bone regeneration and the
synthesis of cartilage.20 In other research, Alves et al.
reported that LLL therapy inhibited the inflammatory
reaction in the early late stages of RA,21 and Sobol et al.
reported that LLL therapy accelerated cellular activity,
especially in cells responsible for cartilage repair.22

Another noteworthy histological finding in our study
was that LLL therapy increased the number of blood
vessels. In research by da Rosa et al., neovascularization
was shown in laser-treated groups on the seventh day of
treatment.23 Dantas et al. suggested that the high rates
of newly formed capillary blood vessels enhanced the
formation of granulation tissue, an initial step in the
healing process.24 LLL therapy causes vasodilation by
enhancing smooth muscle relaxation, which increases
oxygenation of the treated cells and facilitates the
influx of immune cells, thereby accelerating the healing
process.25
Regarding our histochemical results, Masson trichrome
staining showed that the amount of collagen formed in
both of the treated groups was higher than that in the
untreated group. Supporting this, a previous report
indicated that low-dose dexamethasone preserved
matrix formation, decreased proteoglycan and collagen
loss from the ECM, and maintained chondrocyte
vitality in OA.26 Also, LLL therapy has been shown to
accelerate the initial breakdown of cartilage destroyed
by collagenase and to stimulate fibroblasts to produce
collagen type III.27 In this way, LLL therapy may exert
its beneficial effects in OA.
Concerning our qRT-PCR results. LLL therapy at
the selected dose reduced the TNF-α levels, resulting
in an anti-inf lammatory effect superior to that of
dexamethasone. Similarly, LLL therapy may reduce
TNF-α and IL1-β levels, effectively decreasing the
inf lammatory reaction and oxidative stress in rat
tibialis anterior muscles after creating a cryolesion.28
Elsewhere, LLL therapy was reported to decrease the
expression of inflammatory mediators such as IL-1α,
IL-1β, and TNF-α.29
Further objective animal research is now required
to define the optimal parameters for LLL therapy
(e.g., energy doses, frequency, and duration) before
translation into human trials can be justified. Efforts
should also be made to investigate the combined effect
of CS and LLL therapy in treating OA. In addition,
we recommend that other investigatory techniques be
used to clarify the mechanism of the anti-inflammatory
effects of LLL in the treatment of OA. Perhaps more
importantly, however, we must ensure that studies
include long-term follow-up periods so that we
understand the implications of this therapeutic option.

CONCLUSION
We conclude that LLL therapy using the parameters
in this study has anti-inflammatory effects superior to
those of dexamethasone in rats. LLL therapy is a safe,
effective, and non-invasive tool which has the potential
to be applied in a wider scale.
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